|
1）Perlstein TS, Gumieniak O, Williams GH, et al. Uric acid and the development of hypertension: the normative aging study. Hypertension. 2006; 48: 1031-6
|
|
|
|
2）Zhang W, Sun K, Yang Y, et al. Plasma uric acid and hypertension in a Chinese community: prospective study and meta-analysis. Clin Chem. 2009; 55: 2026-34
|
|
|
|
|
|
3）Grayson PC, Kim SY, LaValley M, et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011; 63: 102-10
|
|
|
|
|
|
4）Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008; 300: 924-32
|
|
|
|
|
|
5）Iseki K, Oshiro S, Tozawa M, et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res. 2001; 24: 691-7
|
|
|
|
|
6）Iseki K, Ikemiya Y, Inoue T, et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004; 44: 642-50
|
|
|
|
|
|
7）Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol. 2008; 19: 2407-13
|
|
|
|
|
|
8）Ohno I, Hosoya T, Gomi H, et al. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron. 2001; 87: 333-9
|
|
|
|
|
|
9）Ficociello LH, Rosolowsky ET, Niewczas MA, et al. High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes. Diabetes Care. 2010; 33: 1337-43
|
|
|
|
|
|
10）Huang Y, Li YL, Huang H, et al. Effects of hyperuricemia on renal function of renal transplant recipients: A systematic review and meta-analysis of cohort studies. PLoS ONE. 2012; 7(6): e39457
|
|
|
|
|
|
11）Lapsia V, Johnson RJ, Dass R, et al. Elevated uric acid increases the risk for acute kidney injury. Am J Med. 2012; 125: 302. e9-302. e17
|
|
|
|
|
|
12）Siu YP, Leung KT, Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2005; 47: 51-9
|
|
|
|
|
|
13）Kanbay M, Ozkara A, Selcoki Y, et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions. Int Urol Nephrol. 2007; 39: 1227-33
|
|
|
|
|
|
14）Goicoechea M, de Vinuesa SG, Verdalles U, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol. 2010; 5: 1388-93
|
|
|
|
|
|
15）Whelton A, MacDonald PA, Zhao L, et al. Renal function in gout. Long-term treatment effects of febuxostat. J Clin Rheumatol. 2011; 17: 7-13
|
|
|
|
|
|
16）Talaat KM, El-Sheikh AR. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol. 2007; 27: 435-40
|
|
|
|
|
|
17）Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005; 16: 3553-62
|
|
|
|
|
|
18）Yu MA, Sanchez-Lozada LG, Johnson RJ, et al. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens. 2010; 28: 1234-42
|
|
|
|
|
|
19）Hikita M, Ohno I, Mori Y, et al. Relationship between hyperuricemia and body fat distribution. Internal Medicine. 2007; 46: 1353-8
|
|
|
|
|
|
20）Fabregat I, Revilla E, Machado A. Short-term control of the pentose phosphate cycle by insulin could be modulated by the NADPH/NADP ratio in rat adipocytes and hepatocytes. Biochem Biophys Res Commun. 1987; 146: 920-5
|
|
|
|
|
|
21）Matsubara K, Matsuzawa Y, Jiao S, et al. Relationship between hypertriglyceridemia and uric acid production in primary gout. Metabolism. 1989; 38: 698-701
|
|
|
|
|
|
22）Facchini F, Chen YDI, Hollenbeck CB, et al. Relationship between resistance to insulin mediated glucose uptake, urinary uric acid clearance and plasma uric acid concentration. JAMA. 1991; 266: 3008-11
|
|
|
|
|
|
23）Muscelli E, Natali A, Bianchi S, et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens. 1996; 9(8): 746-52
|
|
|
|
|
|
24）See LC, Kuo CF, Chuang FH, et al. Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clin Rheumatol. 2011; 30: 323-30
|
|
|
|
|
|
25）Abate N, Chandalia M, Cabo-Chan AV, et al. The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance. Kidney Int. 2004; 65: 386-92
|
|
|
|
|
|
26）辻 裕之，宮川めぐみ，有元佐多雄，他．21年間の人間ドックデータからみる血清尿酸値および尿pHとメタボリックシンドローム関連諸因子との関係．人間ドック. 2007; 22: 383-8
|
|
|
|
|